The latest update is out from Integral Diagnostics Ltd. ( (AU:IDX) ).
Integral Diagnostics Ltd. announced a change in the director’s interest notice, specifically regarding Ian Kadish. On March 5, 2025, Kadish acquired 25,000 fully paid ordinary shares through an on-market trade, increasing his total holdings to 610,476 shares. This transaction reflects the director’s confidence in the company’s performance and potential growth, which may positively influence stakeholders’ perception of the company’s stability and future prospects.
More about Integral Diagnostics Ltd.
YTD Price Performance: -26.80%
Average Trading Volume: 1,577,182
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$792M
Learn more about IDX stock on TipRanks’ Stock Analysis page.